Arbutus files patent infringement lawsuit against Pfizer/BioNTech
April 4 (Reuters) - Arbutus Biopharma ABUS.O said on Tuesday it has filed a lawsuit in the New Jersey district court against Pfizer Inc PFE.N and BioNTech SE BNTX.O , claiming their mRNA-LNP COVID-19 vaccines infringe five of Arbutus' patents. (Reporting by Bhanvi Satija in Bengaluru; Editing by Krishna Chandra Eluri) ((Bhanvi.Satija@thomsonreuters.com; Outside U.S. +91 9873062788;))
Recent news on Arbutus Biopharma
See all newsU.S. STOCKS ON THE MOVE-Quest Diagnostics, Tractor Supply, Dutch Bros
Arbutus rises after FDA lifts clinical hold for experimental hepatitis B drug
Brief: Arbutus Announces Final Results Of Its Us$230 Million Modified “Dutch Auction” Tender Offer
Brief: Arbutus Announces Preliminary Results Of Its Us$230 Million Modified “Dutch Auction” Tender Offer
U.S. STOCKS ON THE MOVE-Moderna, O-I Glass, Aveanna Healthcare